⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL112709 | 0.71 | — | — | |
| SCHEMBL4593309 | 0.67 | — | — | |
| SCHEMBL889081 | 0.67 | — | — | |
| SCHEMBL12777890 | 0.67 | — | — | |
| SCHEMBL19140089 | 0.67 | — | — | |
| SCHEMBL1033648 | 0.67 | — | — | |
| SCHEMBL889062 | 0.67 | — | — | |
| SCHEMBL889028 | 0.67 | — | — | |
| SCHEMBL31686419 | 0.67 | — | — | |
| SCHEMBL17533003 | 0.66 | CYP2A6 (0.53) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260138071-A1 | SULFIDE GAS REMOVAL PROCESS | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-05-21 | — | — | US | disclosed |
| US-12605450-B2 | C3-carbon linked glutarimide Degronimers for target protein degradation | C4 THERAPEUTICS, INC. (US) | 2026-04-21 | — | — | US | disclosed |
| US-12577208-B2 | TEAD inhibitors and uses thereof | EHE Foundation (US) | 2026-03-17 | — | — | US | disclosed |
| US-12540127-B2 | CRBN ligands and uses thereof | KYMERA THERAPEUTICS, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| US-20260014514-A1 | METHOD FOR SCAVENGING HYDROGEN SULFIDE FROM A GASEOUS COMPOSITION IN A STIRRED TANK REACTOR | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-01-15 | — | — | US | disclosed |
| US-20260014197-A1 | DRUG DELIVERY SYSTEM | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2026-01-15 | — | — | US | disclosed |
| US-20260014517-A1 | HYDROGEN SULFIDE REMOVAL METHOD FROM DRILLING MUD COMPOSITION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-01-15 | — | — | US | disclosed |
| US-20260008009-A1 | PROCESS FOR REMOVING HYDROGEN SULFIDE FROM A HYDROCARBON GASEOUS COMPOSITION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-01-08 | — | — | US | disclosed |
| US-20260002088-A1 | PROCESS TO REMOVE HYDROGEN SULFIDE FROM A HYDROCARBON-CONTAINING GAS COMPOSITION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-01-01 | — | — | US | disclosed |
| US-20250381514-A1 | METHOD FOR REMOVING HYDROGEN SULFIDE FROM SOUR GAS | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-12-18 | — | — | US | disclosed |
| WO-2005003117-A1 | IMIDAZOLE DERIVATIVES III | F. HOFFMANN-LA ROCHE AG (CH) | 2005-01-13 | — | — | WO | disclosed |
| WO-2004111040-A1 | HETEROARYL-SUBSTITUTED IMDAZOLE DERIVATIVES AS GLUTAMATE RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2004-12-23 | — | — | WO | disclosed |
| US-20040254179-A1 | Heteroaryl-substituted imidazole derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 2004-12-16 | — | — | US | disclosed |
| WO-2004108701-A1 | IMIDAZOLE DERIVATIVES AS GLUTMATE RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2004-12-16 | — | — | WO | disclosed |
| US-20040248888-A1 | Imidazole derivatives | F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) | 2004-12-09 | — | — | US | disclosed |
| US-20040229917-A1 | Imidazole derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 2004-11-18 | — | — | US | disclosed |
| WO-2004080998-A1 | IMIDAZOL-4-YL-ETHYNYL-PYRIDINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2004-09-23 | — | — | WO | disclosed |
| WO-2003047569-A1 | COMPOSITIONS AND METHODS FOR INHIBITING PRENYLTRANSFERASES | GPC BIOTECH, INC. (US) | 2003-06-12 | — | — | WO | disclosed |
| EP-1140858-A2 | ARYLPROPENYLIMIDAZOLES AS FARNESYL-PROTEIN TRANSFERASE INHIBITORS | AstraZeneca AB (SE) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000039716-A2 | ARYLPROPENYLIMIDAZOLES AS FARNESYL-PROTEIN TRANSFERASE INHIBITORS | ASTRAZENECA AB (SE) | 2000-07-06 | — | — | WO | disclosed |